Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

168.23 -0.66 (-0.39%)
Official Closing Price Updated: 7:00 PM EST, Jan 27, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 6,158,105
Open 168.54
Bid (Size) 167.91 (1)
Ask (Size) 168.10 (1)
Prev. Close 168.89
Today's Range 167.77 - 168.87
52wk Range 155.72 - 186.69
Shares Outstanding 2,628,679,824
Dividend Yield 2.40%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
3 Low-Risk Dividend Stocks to Buy in 2023
These stocks should allow you to sleep peacefully no matter what happens with the stock market this year. 
Via The Motley Fool
2 of the Best Dividend Stocks to Own in 2023
You can count on them for passive income and growth over time. 
Via The Motley Fool

Performance

YTD
-5.59%
-5.59%
1 Month
-4.77%
-4.77%
3 Month
-3.80%
-3.80%
6 Month
-3.60%
-3.60%
1 Year
-1.38%
-1.38%

More News

Read More
Stock Market Rally Powers Higher Amid Big Earnings From Tesla, Boeing, Microsoft, American Express: Weekly Review
Via Investor's Business Daily
Johnson & Johnson (JNJ) Q4 2022 Earnings Call Transcript
Via The Motley Fool
3 Must-Own Dividend Stocks
Via The Motley Fool
Intraday Technical Analysis Of Johnson & Johnson
Via Talk Markets
The 3 Best Biotech Stocks Under $1 to Buy for January
Via InvestorPlace
3 Warren Buffett Stocks That Could Make You Richer in 2023
Via The Motley Fool
Is Johnson & Johnson Still a Good Dividend Stock to Buy?
Via The Motley Fool
3 Perfect Stocks for Retirees to Buy Hand Over Fist During the Nasdaq Bear Market
Via The Motley Fool
Two Dividend Kings: Johnson & Johnson or Abbott Laboratories?
Via MarketBeat
Topics Economy
Exposures Interest Rates
Union Pacific To Rally Over 11%? Here Are 10 Other Analyst Forecasts For Wednesday
Via Benzinga
Nasdaq Futures Slump As Microsoft's Outlook Dampens Tech Recovery Expectations — Analyst Warns Of More Bumpiness By Mid-February
Via Benzinga
3 Reasons Why Johnson & Johnson Stock Could Rebound After a Bad Start in 2023
Via The Motley Fool
How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
Via MarketBeat
Topics Workforce
Exposures Layoff Product Safety
Why Johnson & Johnson Stock Was Stagnant Today
Via The Motley Fool
The Earnings Shall Continue! Today's Key Updates For You
Via Talk Markets
Most Active Equity Options For Midday - Tuesday, Jan. 24
Via Talk Markets
Why Are Stocks Down Today?
Via InvestorPlace
Trump Beefs Up Defamation War Against New York Prosecutor, Apple Weighs Content Deals With Disney, Likely Lawsuit On Google For Influencing Online Ad Market: Today's Top Stories
Via Benzinga
Johnson & Johnson Beats Profit Views, But Light Sales, Outlook Chip At Shares
Via Investor's Business Daily
Johnson & Johnson Q4 Earnings Top Estimates
Via Talk Markets
Johnson & Johnson Reports Mixed Q4 Earnings, Issues FY23 Guidance Edging Higher Than Street Consensus
Via Benzinga
US Stocks Look Set For Lower Start On Tuesday Ahead Of Microsoft's Earnings: Analysts Caution Of More Near-Term Volatility
Via Benzinga
Johnson & Johnson Reports Q4 and Full-Year 2022 Results
From Johnson & Johnson
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.